Author:
Uomoto Mari,Ota Yukihide,Suzuki Yukio,Yumori Asuna,Narimatsu Hiroto,Koizume Shiro,Sato Shinya,Nakamura Yoshiyasu,Myoba Shohei,Ohtake Norihisa,Saji Haruya,Miyagi Etsuko,Miyagi Yohei
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48.
2. World Cancer Research Fund International. Endometrial cancer statistics 2024. https://www.wcrf.org/cancer-trends/endometrial-cancer-statistics/. Accessed 15 July 2024.
3. Chao A, Tang YH, Lai CH, Chang CJ, Chang SC, Wu TI, et al. Potential of an age-stratified CA125 cut-off value to improve the prognostic classification of patients with endometrial cancer. Gynecol Oncol. 2013;129:500–4.
4. Jiang T, Huang L, Zhang S. Preoperative serum CA125: a useful marker for surgical management of endometrial cancer. BMC Cancer. 2015;15:396.
5. Wang C, Li J, Liu W, Li S, Zhang Y, Jin Y, et al. Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer. Aging. 2023;15:8744–69.